Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Exxon Mobil | 2.25% | $2.87M | $498.26B | 12.24% | 74 Outperform | |
| Chevron | 1.76% | $2.24M | $301.63B | 4.64% | 71 Outperform | |
| Johnson & Johnson | 1.74% | $2.21M | $499.50B | 41.09% | 78 Outperform | |
| AbbVie | 1.44% | $1.84M | $402.80B | 27.10% | 66 Neutral | |
| HSBC Holdings | 1.34% | $1.71M | HK$2.11T | 52.23% | 80 Outperform | |
| Philip Morris | 1.29% | $1.64M | $248.60B | 31.85% | 61 Neutral | |
| Altria Group | 1.24% | $1.58M | $98.39B | 9.87% | 64 Neutral | |
| Merck & Company | 1.24% | $1.57M | $259.92B | 5.62% | 80 Outperform | |
| Intesa Sanpaolo SpA | 1.19% | $1.51M | €102.18B | 53.81% | 76 Outperform | |
| Nestlé SA | 1.16% | $1.48M | CHF197.21B | 18.81% | 71 Outperform |